The Food and Drug Administration (FDA) has published a new Clinical Outcome Assessment (COA) Compendium, intended to serve as a starting point when considering a COA for use in clinical trials. A COA is an assessment of a clinical outcome that can be made via a report by a clinician, a patient, a non-clinician observer or through a performance-based assessment. The COA Compendium is a communication tool and does not represent FDA guidance.

View LinkedIn Profile

Shack Cookies Restrict

This website uses cookies to properly administer the site and improve your experience. Continuing to use this website indicates your acceptance. Please click "accept" to remove this message.